United Therapeutics
UTHR
#1127
Rank
HK$172.21 B
Marketcap
HK$4,015
Share price
-0.73%
Change (1 day)
69.72%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2026 (TTM): HK$228.98

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is HK$230.05. In 2025 the company made an earnings per share (EPS) of HK$236.80 an increase over its 2024 EPS that were of HK$207.53.

EPS history for United Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$228.98-3.3%
2025HK$236.8014.1%
2024HK$207.5325.59%
2023HK$165.2431.54%
2022HK$125.6251.18%
2021HK$83.09-9.1%
2020HK$91.41-581.4%
2019-HK$18.99-117.79%
2018HK$106.7142.11%
2017HK$75.09-40.93%
2016HK$127.1113.45%
2015HK$112.05104.29%
2014HK$54.85100.29%
2013HK$27.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.28-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.46-3.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-HK$16.71-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$58.22-74.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
HK$51.55-77.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.49-86.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
-HK$53.67-123.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$10.75-95.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel